Clinical Evaluation of Antitumor Therapy
β Scribed by Franco M. Muggia, Marcel Rozencweig (auth.), Franco M. Muggia M.D., Marcel Rozencweig M.D. (eds.)
- Publisher
- Springer US
- Year
- 1986
- Tongue
- English
- Leaves
- 223
- Series
- Developments in Oncology 46
- Edition
- 1
- Category
- Library
No coin nor oath required. For personal study only.
β¦ Synopsis
The methodology of drug development has been the subject of extensive disΒ cussion by a relatively small group of individuals in industry and government who have been intimately concerned with the identification and study of new anticancer drugs. The Chemotherapy Program of the National Cancer InΒ stitute has represented the major focus of initial efforts in drug development, as summarized in the historical perspective presented in chapter 1 and its references. It is no coincidence that the Chemotherapy Program was the origin of the Division of Cancer Treatment, a government entity that has had a pivotal role in the growth of clinical oncology. In an analogous fashion this book presents the methodology employed in the clinical study of anticancer drugs within the broad context of cancer treatment. The research orientation promulgated in the study of new drugs is a central theme in most oncoloΒ gists' approach to the clinical problem of cancer. Therefore, we hope that this book will introduce readers to treatment research in clinical oncology. For the oncologist, the clinical evaluation of antitumor therapy is both part of the day-to-day management of specific patients and the critical consideraΒ tion of developing therapeutic alternatives. For physicians in other fields of medicine it is important to acquaint themselves with the basic tools of the oncologist. For people without medical training, including patients who might be interested in treatment research, many of the chapters may be overly technical.
β¦ Table of Contents
Front Matter....Pages i-xii
General Issues in Anticancer Drug Development....Pages 3-16
Animal Tumor Models for Experimental Therapy....Pages 17-31
Experimental Therapy: In Vitro Models....Pages 33-53
Clinical Evaluation: Noninvasive Methods....Pages 55-83
Clinical Evaluation: Biochemical Methods....Pages 85-115
Anatomic and Surgical Principles in Cancer Clinical Trials....Pages 117-131
Experimental Toxicology....Pages 133-152
The Phase I Study: General Objectives, Methods, and Evaluation....Pages 153-174
Clinical Evaluation of Anticancer Treatments: Phase II Clinical Trials....Pages 175-197
Analysis of Clinical Trial Data....Pages 199-210
The Strategy of Cancer Treatment....Pages 211-216
Back Matter....Pages 217-219
β¦ Subjects
Oncology
π SIMILAR VOLUMES
<p>Reveals important new results from clinical trials conducted in Scandinavia, Scotland, Australia, Canada, and the United States.</p><p>This timely reference reviews the vast body of clinical trial evidence supporting the once controversial view that high levels of serum cholesterol are a major ri
<p>When I was about fifteen, my Biological Seiences teacher, Prof. N. Benacchio, lent me a book by Paul de Kruif "The Microbe Hunters" and I remained fascinated by infectious diseases. I was intrigued by the potency of virulent bacteria which are constantly trying to invade our bodies and often over
<p>Modern drugs are invented according to medical needs, making use of the latest innovations in technology. They are sophisticated, efficacious, and costly, but are they effective? Are they superior to existing - and cheaper - alternatives, and is this superiority reflected in increased cost-effect
<p>This comprehensive survey will be useful for anyone who seriously wants to learn more about the current therapeutic status of biofeedback-therapists, physicians considering a referral, well-educated prospective patients, teachers, students, and research workers. But readers with different needs s
Updated by a team of internationally renowned experts, this book gives a thorough overview of fetal pathophysiology and an evidence base for in utero: both medical (non-invasive) and surgical treatments. Many topics are expanded to cover recent advances, including: stem cell transplantation; tissue